July 6, 2020 / 8:36 PM / a month ago

BRIEF-Chembio Announces Plans To Seek EUA Approval From FDA For Revised DPP Covid-19 Igm/Igg System And New DPP Covid-19 Antigen System

July 6 (Reuters) - Chembio Diagnostics Inc:

* CHEMBIO ANNOUNCES PLANS TO SEEK EUA APPROVAL FROM FDA FOR REVISED DPP COVID-19 IGM/IGG SYSTEM AND NEW DPP COVID-19 ANTIGEN SYSTEM

* CHEMBIO DIAGNOSTICS INC - REVISING ITS DPP COVID-19 IGM/IGG SYSTEM WITH OBJECTIVE OF MEETING FDA’S NEW CRITERIA, INCLUDING USE OF NCI PROCESS

* CHEMBIO DIAGNOSTICS INC - EXPECTS, BASED ON ITS DEVELOPMENT EFFORTS TO DATE, TO APPLY FOR AN EUA FOR REVISED SYSTEM DURING Q3 OF 2020

* CHEMBIO DIAGNOSTICS INC - CONTINUES TO OFFER DPP COVID-19 IGM/IGG SYSTEM OUTSIDE U.S. Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below